Blog
RSS FeedPosted by Michael Wonder on 20 May 2019
Europe responding to gene therapy challenge, but picture remains fragmented
20 May 2019 - Germany, Italy and England using outcomes-based deals. ...
Posted by Michael Wonder on 19 May 2019
House passes legislation aiming to shore up health law and lower drug costs
16 May 2019 - The House on Thursday passed a suite of health care bills that tied shoring up the ...
Posted by Michael Wonder on 19 May 2019
Push for drug pricing transparency strikes a nerve with industry
19 May 2019 - Ahead of the World Health Assembly in Geneva, an Italian draft resolution to end secrecy around ...
Posted by Michael Wonder on 19 May 2019
Australians want cheaper medicines quicker
20 May 2019 - Just last week, an 18-year-old woman with a rare cancer was staring down the barrel of ...
Posted by Michael Wonder on 19 May 2019
Cost of EpiPens putting children at risk, specialists say
19 May 2019 - Children with life-threatening allergies whose families cannot afford to pay for EpiPen auto-injectors are at serious ...
Posted by Michael Wonder on 18 May 2019
Trump just pulled his punch on drug prices
18 May 2019 - Actually cutting health care costs will require overcoming opposition instead of ducking it, as his administration did ...
Posted by Michael Wonder on 18 May 2019
Athersys announces fast track designation from FDA for MultiStem program for acute respiratory distress syndrome
14 May 2019 - Athersys announced today that its clinical program evaluating MultiStem cell therapy for the treatment of acute respiratory ...
Posted by Michael Wonder on 18 May 2019
Agile Therapeutics resubmits new drug application for its transdermal low-dose contraceptive patch, Twirla
17 May 2019 - Agile Therapeutics today announced it has resubmitted to the U.S. FDA the new drug application for its ...
Posted by Michael Wonder on 18 May 2019
U.S. FDA approves Gattex (teduglutide) for children 1 year of age and older with short bowel syndrome
17 May 2019 - Gattex is the only glucagon-like peptide-2 analogue approved that improves intestinal absorption in patients with SBS who ...
Posted by Michael Wonder on 18 May 2019
NICE recommends Revlimid as multiple myeloma alternative
17 May 2019 - NICE has recommended Revlimid (lenalidomide), a drug that helps to support the immune system to fight ...
Posted by Michael Wonder on 17 May 2019
Celgene receives European Commission approvals for Revlimid (lenalidomide) and Imnovid (pomalidomide)-based triplet combination regimens for patients with multiple myeloma
16 May 2019 - The European Commission has approved two of Celgene’s IMiD based combination regimens. ...
Posted by Michael Wonder on 17 May 2019
Health technology assessment challenges in oncology: 20 years of Value in Health
16 May 2019 - Oncology treatments have changed from chemotherapies to targeted therapies and more recently immuno-oncology. ...
Posted by Michael Wonder on 17 May 2019
Health Canada approves injectable hydromorphone to treat opioid addiction
16 May 2019 - Canada is first country to approve the pain drug for severe opioid use disorder, says Health ...
Posted by Michael Wonder on 16 May 2019
Instalment payments could be used across gene therapy space, Spark CEO says
16 May 2019 - In a fireside chat at the recently concluded Veeva Summit in Philadelphia, Jeff Marrazzo said payment over ...
Posted by Michael Wonder on 16 May 2019
Pharma industry improves access to medicines in developing world
16 May 2019 - Pharmaceutical companies have made good progress in promoting global health over the past 10 years by ...
Posted by Michael Wonder on 16 May 2019
Mum delivers 65 roses to Downing Street in bid to speed up NHS availability of vital cystic fibrosis drugs
16 May 2019 - Calls for NHS access to potentially life-saving drugs are growing, one year to the day after ...